Navigation Links
Sensors, a smart dose of medicine for cancer treatment

or systems will improve treatment verification for a large number of cancer patients.

"The prevailing opinion is that IMRT improves treatment outcomes," says Jaksic. "Crucially, IMRT reduces the side-effects patients often suffer from radiotherapy and improves accuracy of dose delivery, and these are the most important impacts in the treatment of cancer."


'"/>

Source:IST Results


Page: 1 2 3

Related biology news :

1. MIT engineers an anti-cancer smart bomb
2. Genetic testing still smart choice, despite uncertainties
3. Making medicine smarter
4. Outsmarting the smartie bug
5. UCSD researchers develop smart petri dish
6. What controls stickiness of smart chromosomal glue
7. Heart smart: new drug improves blood flow
8. Compound from Chinese medicine shows promise in head and neck cancer
9. FDA approves child-friendly AIDS medicine
10. MIT chemist discovers secret behind natures medicines
11. Traditional Chinese medicine for diabetes has scientific backing

Post Your Comments:
(Date:12/2/2009)..., , REDWOOD SHORES, Calif. and PALM...mmunication Intelligence Corporation ("CIC") (OTC ...ronic signature solutions for business process aut...zed leader** in biometric signature verification a...nternational Electronic Document Management (EDM) ...
(Date:12/2/2009)..., Single-walled nanotubescylinders of carbon about...r potential applications such as ultrastrong fiber...gen storage components for fuel cells. Thanks to a...stitute of Standards and Technology (NIST) and fiv...e list: detection and destruction of an aggressive...
(Date:12/2/2009)..., A scientist from the University of Salamanca and...presence of predators affects the behaviour of Ac...m the Negev Desert in the Near East. According to ... mobile and different prey if they are under press...d predicted this result, but until now there had b...
Breaking Biology News(10 mins):CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 3CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 4Combining nanotubes and antibodies for breast cancer 'search and destroy' missions 2Lizards change their diet to avoid predators 2Isis Pharmaceuticals to Present at the 2009 Canaccord Adams Cardiovascular Conference 5940 1MarketsandMarkets 3A Global Stem Cell and Advanced Technologies Market Worth US 24 88 3 Billion By 2014 14699 1MarketsandMarkets 3A Global Stem Cell and Advanced Technologies Market Worth US 24 88 3 Billion By 2014 14699 2MarketsandMarkets 3A Global Stem Cell and Advanced Technologies Market Worth US 24 88 3 Billion By 2014 14699 3Medical Device Software Engineering Firm Full Spectrum Software Appoints Cindy Larkin to Director of Client Services 14697 1Medical Device Software Engineering Firm Full Spectrum Software Appoints Cindy Larkin to Director of Client Services 14697 2
...n Molecular Biology Organization (EMBO) announced ... young researchers as the 2007 beneficiaries of it...h year since 2000, the programme identifies and su.... Recipients receive academic, practical and finan... independent careers. , Selected by EMBO Members...
...t. 22 Emphysema patients whose lungs are implante...l valve experience significantly improved measures...e, University of Pittsburgh School of Medicine res...CHEST 2007, the annual meeting of the American Col...inue through Thursday, Oct. 25, at the McCormick P...
...en elderly nursing home residents contract pneumon...Simin Nikbin Meydani, DVM, PhD of the Jean Mayer U...fts University and colleagues report that maintain...ay help reduce the risk of pneumonia development i...rs that daily zinc intake can help nursing home re...
Other Biology News:18 young scientists join EMBO Young Investigator network 2Endobronchial valve significantly improves emphysema 2Zinc may reduce pneumonia risk in nursing home elderly 2
(Date:12/2/2009)...a, Dec. 2 /PRNewswire-Asia/ -- Simcere Pharmaceuti...R ), a leading pharmaceutical company,specializing...of branded,generic and proprietary pharmaceuticals...ave been included in China,s National Drug Reimbur...Ministry of Human Resources and Social,Security on...
(Date:12/2/2009)...ientist, a leading scientific magazine covering th... “Intelligent” EMCCD camera fourth amo...ns of 2009. , (PRWEB) Dec...from Photometrics ®, a designer and manufact... the life sciences, was ranked fourth among The Sc...
(Date:12/1/2009)..., Dec. 1 PDL BioPharma, ...e guidance for the fourth quarter ended December 3...with $69 million for the fourth quarter of 2008. I...st of two installment payments of $12.5 million fr...results was a one-time $1.8 million payment from G...
(Date:12/1/2009)... 1 Reportlinker.com announces that...catalogue: ,, Emerging Clinical Trial Location...ng healthcare and regulatory environment ,, h...cal-Trial-Locations---Eastern-Europe-Market-dynami...ronment.html ,, Over the last decade pharmaceu...
Breaking Biology Technology:Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 2The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 3PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 2Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 3Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 4Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 5Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 6Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 7Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 8
...ed corticosteroid inhaler approved ... Aug. 19 Schering-Plough,Corporation (NYSE: SGP ...0,mcg (mometasone furoate inhalation powder) is no...ndicated for the maintenance treatment of asthma a...ge and older, and is the,first and only once-daily...
...c., a,leader in human embryonic stem cell derived ... an exclusive worldwide technology licensing agree...ation that will enable the,company to commercializ...ity of Georgia., (Logo: http://www.newscom.com/c...rms of the agreement, ArunA has acquired an exclus...
... ,endometrial regenerative cells, (ERCs) are capab...dvanced peripheral artery disease. A study publish...f Translational Medicine demonstrates that when ci...tions, circulation and functionality were restored... peripheral artery disease, causes approximately 1...
Other Biology Technology:Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11 2Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11 3Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11 4Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11 5Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11 6Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11 7Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11 8ArunA Biomedical Announces Exclusive Worldwide Technology Licensing Agreement to Commercialize Human Embryonic Stem Cell Derived Mesenchymal Cells 2Limbs saved by menstrual blood stem cells 2
Cytomics FC 500 Series Flow Cytometry Systems from Beckman Coulter
... can provide custom microplate coating using advan...g equipment that dispenses and washes a variety of...any lot size of the following formats (with a volu...ips, 96 well microplate, 384 well microp...
Mynox Mycoplasma Elimination Reagent from Minerva Biolabs GmbH
Coating Solution Concentrate Kit from KPL
Biology Products: